Document:

EXHIBIT 4.9

 

DESCRIPTION OF CAPITAL STOCK

 

Our authorized capital stock consists of 250,000,000
shares of common stock, $0.001 par value per share, and 25,000,000 shares of blank check preferred stock, $0.001 par value per share.
As of March 31, 2022, there are 113,187,898 shares of common stock and 0 shares of preferred stock outstanding.

 

This description is intended as a summary, and is
qualified in its entirety by reference to our amended and restated articles of incorporation and amended and restated by-laws, which are
filed, or incorporated by reference, as exhibits to our filings with the Securities and Exchange Commission.

 

Common Stock

 

Holders of our common stock are entitled to one vote
for each share held of record on all matters submitted to a vote of the stockholders, and do not have cumulative voting rights. Subject
to preferences that may be applicable to any outstanding shares of preferred stock, holders of common stock are entitled to receive ratably
such dividends, if any, as may be declared from time to time by our Board of Directors out of funds legally available for dividend payments.
All outstanding, shares of common stock are fully paid and nonassessable. The holders of common stock have no preferences or rights of
cumulative voting, conversion, or pre-emptive or other subscription rights. There are no redemption or sinking fund provisions applicable
to the common stock. In the event of any liquidation, dissolution or winding-up of our affairs, holders of common stock will be entitled
to share ratably in any of our assets remaining after payment or provision for payment of all of our debts and obligations and after liquidation
payments to holders of outstanding shares of preferred stock, if any.

 

Warrants

 

November 2020 

 

The following is a summary of certain terms and provisions
of warrants issued in November 2020 (the “Warrants”).

 

The Warrants entitle the registered holder to purchase
one share of our common stock at a price equal to $9.80 per share, subject to adjustment as discussed below, immediately following the
issuance of such warrant and terminating at 5:00 p.m., New York City time, on November 27, 2023.

 

The exercise price and number of shares of common
stock issuable upon exercise of the Warrants may be adjusted in certain circumstances, including in the event of a stock dividend or recapitalization,
reorganization, merger or consolidation. However, the warrants will not be adjusted for issuances of common stock at prices below its
exercise price.

 

Exercisability. The Warrants are exercisable at any
time after their original issuance and at any time up to the date that is three (3) years after their original issuance. The warrants
may be exercised upon surrender of the warrant certificate on or prior to the expiration date at the offices of the Company, with the
exercise form on the reverse side of the warrant certificate completed and executed as indicated, accompanied by full payment of the exercise
price, by certified or official bank check payable to us, for the number of Warrants being exercised.

 

Exercise Limitation. A holder may not exercise any
portion of a Warrant to the extent that the holder, together with its affiliates and any other person or entity acting as a group, would
own more than 4.99% of the outstanding common stock after exercise, as such percentage ownership is determined in accordance with the
terms of the Warrant, except that upon prior notice from the holder to us, the holder may waive such limitation up to a percentage not
in excess of 9.99%.

 

Exercise Price. The exercise price per whole share
of common stock purchasable upon exercise of the Warrants is $9.80 per share. The exercise price is subject to appropriate adjustment
in the event of certain stock dividends and distributions, stock splits, stock combinations, reclassifications or similar events affecting
our common stock and also upon any distributions of assets, including cash, stock or other property to our stockholders.

 

    	 

    	 

    

 

Fractional Shares. No fractional shares of common
stock will be issued upon exercise of the Warrants. If, upon exercise of the Warrant, a holder would be entitled to receive a fractional
interest in a share, we will, upon exercise, pay a cash adjustment in respect of such fraction in an amount equal to such fraction multiplied
by the exercise price. If multiple Warrants are exercised by the holder at the same time, we shall pay a cash adjustment in respect of
such final fraction in an amount equal to such fraction multiplied by the exercise price.

 

Transferability. Subject to applicable laws, and the
restrictions set forth under the Form of Warrant, the Warrants shall not be offered for sale, sold, transferred or assigned for one hundred
eighty (180) days following the Effective Date, the lock-up period.

 

Fundamental Transactions. In the event of a fundamental
transaction, as described in the Warrants and generally including any reorganization, recapitalization or reclassification of our common
stock, the sale, transfer or other disposition of all or substantially all of our properties or assets, our consolidation or merger with
or into another person, the acquisition of more than 50% of our outstanding common stock, or any person or group becoming the beneficial
owner of 50% of the voting power represented by our outstanding common stock, the holders of the Warrants will be entitled to receive
the kind and amount of securities, cash or other property that the holders would have received had they exercised the warrants immediately
prior to such fundamental transaction.

 

Rights as a Stockholder. The Warrant holders do not
have the rights or privileges of holders of common stock or any voting rights until they exercise their Warrants and receive shares of
common stock. After the issuance of shares of common stock upon exercise of the Warrants, each holder will be entitled to one vote for
each share held of record on all matters to be voted on by stockholders.

 

May 2021 

 

The following is a summary of certain terms and provisions
of warrants issued in May 2021.

 

Each Series A Warrant entitles the registered holder
to purchase one share of Common Stock at a price equal to $5.07 per share, subject to adjustment as discussed below, terminating at 5:00
p.m., New York City time, on the fifth (5th) anniversary of the date of issuance. No fractional warrants will be issued and only whole
warrants are exercisable. The exercise price and number of shares of Common Stock issuable upon exercise of the Series A Warrants may
be adjusted in certain circumstances, including in the event of a stock dividend, extraordinary dividend on or recapitalization, reorganization,
merger or consolidation. If the Company fails to maintain a current prospectus or prospectus relating to the Common Stock issuable upon
the exercise of the Series A Warrants, holders may exercise their Series A Warrants on a “cashless” basis pursuant to a formula
set forth in the terms of the Series A Warrants. If at any time the closing price per share of the Common Stock shall exceed 300% of the
exercise price then in effect for five consecutive trading days on each of which the daily dollar volume of the Common Stock equals or
exceeds $5,000,000, the Company, at its option, may redeem the Series A Warrants, in whole or in part, at a price of $0.001 per share
(subject to adjustment as provided therein).

 

Each Series B Warrant entitles the holder thereof
to purchase one-half of a share of Common Stock at an exercise price of $6.59 per whole share, subject to adjustment as discussed below,
terminating at 5:00 p.m., New York City time, on the fifth (5th) anniversary of the date of issuance. No fractional warrants will be issued
and only whole warrants are exercisable. The exercise price and number of shares of Common Stock issuable upon exercise of a whole Series
B Warrant may be adjusted in certain circumstances, including in the event of a stock dividend, extraordinary dividend on or recapitalization,
reorganization, merger or consolidation. If the Company fails to maintain a current prospectus or prospectus relating to the Common Stock
issuable upon the exercise of the Series B Warrants, holders may exercise their Series B warrants on a “cashless” basis pursuant
to a formula set forth in the terms of the Series B Warrants. If at any time the closing price per share of the Common Stock shall exceed
300% of the exercise price then in effect for five consecutive trading days on each of which the daily dollar volume of the Common Stock
equals or exceeds $5,000,000, the Company, at its option, may redeem the Series B Warrants, in whole or in part, at a price of $0.001
per share (subject to adjustment as provided therein).

 

Warrant holders, subject to limited exceptions, cannot
exercise their warrants to the extent that, after giving effect to such exercise, the holder (together with its affiliates) would beneficially
own in excess of 4.99% (or, at the election of the purchaser, 9.99%; subject to increase at the option of the holder to 9.99% upon 61
days’ prior written notice) of the Company’s Common Stock outstanding immediately after giving effect to the exercise.

 

Preferred Stock

 

Our certificate of incorporation authorizes our board
of directors to issue 25,000,000 Preferred Stock, par value $0.001 per share and to fix the rights, preferences, privileges and restrictions,
including voting rights, of these shares, without further stockholder approval. Our Board of Directors has the authority, without further
stockholder authorization, to issue from time to time shares of preferred stock in one or more series and to fix the terms, limitations,
relative rights and preferences and variations of each series. Currently there are no outstanding shares of preferred stock.Exhibit
10.53

 

 

 

 

	 

    Service
    Agreement

    

    for
    Chief Executive Officer

     

    Alset
    International Limited

     

    (the
    Company)

     

    and

     

    Chan
    Heng Fai Ambrose

     

    (the
    Executive)
	 

     

    

     

     

     

     

     

     

     

     

     

     

     

     

    Shook
    Lin & Bok LLP

    1 Robinson
    Road

    #18-00 AIA
    Tower

    Singapore
    048542

     

    T +65 6535
    1944

    F +65 6535
    8577

    E slb@shooklin.com

 

    	 

     

    

 

This
Agreement is made on this 10th day of December 2021.

 

Between:

 

	(1)	Alset
                                            International Limited (Company Registration Number 200916763W), a company incorporated
                                            in Singapore and having its registered office at 7 Temasek Boulevard #29-01B Suntec Tower
                                            One Singapore 038987 (the “Company”); and
	 	 
	(2)	Chan
                                            Heng Fai Ambrose (the “Executive”).

 

It
is agreed as follows:

 

	1.	Definitions
	 	 
	1.1	In
                                            this Agreement except as far as the context otherwise requires, the following expressions
                                            have the following meanings respectively:

 

Appointment
means the employment of the Executive by the Company established under the terms and subject to the conditions of this Agreement;

 

Associates
shall have the meaning ascribed to it in the Catalist Rules;

 

Associated
companies shall have the meaning ascribed to it in the Catalist Rules;

 

Board
means the board of directors of the Company from time to time;

 

Catalist
Rules means the SGX-ST Listing Manual Section B: Rules of Catalist, as may be amended or modified from time to time;

 

Companies
Act means the Companies Act, Cap. 50 of Singapore, as may be amended or modified from time to time;

 

Financial
Year means the period of 12 months commencing on 1 January and ending 31 December of each calendar year;

 

Group
means the Company, its subsidiaries and associated companies from time to time;

 

Group
Company means any one of the companies within the Group regardless of any percentage of shareholding;

 

S$
means the lawful currency of the Republic of Singapore;

 

SGX-ST
means the Singapore Exchange Securities Trading Limited; and

 

Subsidiaries
shall have the meaning ascribed to it in the Companies Act.

 

	1.2	The
                                            headings of this Agreement shall not affect its interpretation.
	 	 
	1.3	Unless
                                            the context otherwise requires or permits, references to the singular number shall include
                                            references to the plural number and vice versa, and references to natural persons
                                            shall include firms, associations and bodies corporate and vice versa.

 

    	 

     

    

 

		2.	Appointment

 

	2.1	The
                                            Company shall employ the Executive and the Executive shall serve the Company as the Chief
                                            Executive Officer of the Company or in such other capacity as the Board may deem advisable
                                            from time to time.
	 	 
	2.2	The
                                            Appointment shall commence on 25 March 2020 and shall end on 24 March 2030 (the “Term”),
                                            and shall thereafter be automatically renewed on an annual basis on the same terms and conditions
                                            unless terminated in accordance with Clause 7 below.

 

		3.	Duties

 

	3.1	The
                                            Executive shall undertake such responsibilities, diligently perform such duties and exercise
                                            such powers in relation to the Group and its business as may from time to time be assigned
                                            to him by or under the authority of the Board or vested in the Executive and shall comply
                                            with all regulations and directions made by or under the authority of the Board from time
                                            to time.
	 	 
	3.2	During
                                            the Appointment, the Executive shall faithfully serve the Group and use his utmost endeavours
                                            to promote the interests of the Group and shall devote his time, attention, abilities and
                                            skill to the affairs of the Group. In addition, the Executive shall use all proper means
                                            in his power to develop, extend, maintain, advance and promote the business of the Group
                                            and to protect and further the reputation, interests and success of the Group.
	 	 
	3.3	The
                                            Executive shall (without further remuneration) undertake such responsibilities and perform
                                            such duties as the Company may from time to time require, including, and without limiting,
                                            the generality of the foregoing:

 

		(a)	to
                                            act as an officer, director, chief executive officer and chairman of the Company;
	 	 	 
		(b)	to
                                            carry out duties on behalf of any Group Company;
	 	 	 
		(c)	to
                                            act as an officer, director, chief executive officer and chairman of any Group Company or
                                            hold any other appointment or office as nominee or representative of the Company or any Group
                                            Company; and
	 	 	 
		(d)	to
                                            carry out such duties and the duties attendant on any such appointment or office as if they
                                            were duties to be performed by him on behalf of the Company.

 

	3.4	The
                                            Company acknowledges that the Executive is also involved in the management of personal and
                                            family investments, banking and finance, and has multiple investments around the world, and
                                            is a board member and even Chairman of many publicly traded companies and non-publicly traded
                                            companies. It is expressly understood by the Company that that the Executive is allowed to
                                            continue to be involved in these activities.

 

		4.	Remuneration

 

		4.1	The
                                            Executive’s salary shall be at the rate of S$1.00 per month (“Base
                                            Salary”).
	 	 	 
		4.2	In
                                            addition, the Executive is eligible for annual performance bonuses which shall be based on
                                            the following:

 

		(a)	5%
                                            of the Market Capitalisation Growth of the Company (“Incentive#1”); and
	 	 	 
		(b)	5%
                                            of the annual Net Asset Value (NAV) change of the Company as audited (“Incentive#2”)

 

(collectively,
the “Performance Bonus”).

 

Incentive#1:

 

“Market
Capitalization Growth” shall mean the increase in the fiscal year over year value of the Company’s Market Cap. The Company’s
“Market Cap” is equal to the product of (a) the total number of outstanding ordinary shares as of December 31, as reported
by the Company’s Share Registrar, and (b) the 10 trading days volume weighted average price (“VWAP”) of the
Company’s ordinary shares on the principal trading market prior to December 31 of each year, as reported by the SGX-ST or other
reliable source as to the Company and the Executive may mutually agree. However, the growth bonus shall be deemed zero for the purposes
of this calculation if the Market Capitalization Growth is less than 0%.

 

    	2

    	 

    

 

For
illustration purposes only:

 

If
the Company’s Market Cap as at:

 

Period
1: December 31, 2021 = $50,000,000 ($1.00 10-day VWAP with 50,000,000 shares outstanding)

 

Period
2: December 31, 2022 = $100,000,000 ($2.00 10-day VWAP with 50,000,000 shares outstanding)

 

Calculation:

 

(Period
2 minus Period 1) x .05, or ($100,000,000 - $50,000,000) x.05 = $2,500,000

 

Therefore,
total bonus associated with Market Capitalization Growth = $2,500,000.

 

Incentive#2:

 

“Net
Asset Value Change” shall mean the increase in year over year value of the Company’s NAV calculated as at December 31
of each year in accordance with the publication of the Company’s consolidated annual audited financial statements. The Company’s
“NAV” is equal to the Company’s total assets minus total liabilities determined in the audited financial statements.
However, the NAV bonus shall be deemed zero for the purposes of this calculation if the Net Asset Value Change is less than 0%.

 

For
illustration purposes only:

 

If
the NAV of the Company as at:

 

Period
1: December 31, 2021 = $3,000,000

 

Period
2: December 31, 2022 = $3,600,000

 

Calculation:

 

(Period
2 minus Period 1) x .05, or ($3,600,000 - $3,000,000) x.05 = $30,000

 

Therefore,
total bonus associated with Net Asset Value Change = $30,000.

 

The
calculation, administration and payment of the Performance Bonus will be determined on an annual basis and will be payable annually.
The calculation of the Performance Bonus shall be made within seven (7) days after the Company’s fiscal year end for Incentive#1
and within seven (7) days after the publication of the consolidated annual audited financial statements for Incentive#2.

 

The
Executive shall make an election of cash, shares or a combination as to the payment method of the Performance Bonus within fourteen (14)
days; and after electing the payment method, the Performance Bonus shall be paid to the Executive within fourteen (14) days. The first
Performance Bonus will be computed based on the fiscal year ended 31 December 2020 and the fiscal year ended 31 December 2019.

 

If
the Executive elects to have either the Base Salary and/or the Performance Bonus paid in the Company’s ordinary shares, the Executive
must make the request in writing to the Company’s CEO or CFO. The conversion rate from cash to the shares shall be based on the
10 trading days VWAP of the Company’s ordinary shares immediately before the date the Executive makes the written request to elect
payment in shares. The Company shall make the necessary arrangements for the shares to be paid to the Executive within one (1) month
from the date of the Executive’s written request. Such payment may be made by physical share certificate or by electronic deposit
to his designated stock brokerage account.

 

    	3

    	 

    

 

	4.3	The
                                            Company and the Executive shall make all relevant payments required by applicable law to
                                            be made by the Company and/or the Executive in Singapore and/or any other jurisdiction in
                                            which the Executive may be based or posted. The salary shall be deemed to accrue from day
                                            to day. The Company reserves the right to deduct from the Executive’s salary and/or
                                            any other sums due to the Executive any amount in respect of the Executive’s contribution
                                            to any applicable pension fund or any amount whatsoever, as the Company may be entitled to
                                            deduct or as may be required by applicable law and/or regulation.
	 	 
	4.4	The
                                            Executive shall be responsible for the payment of his income tax on the said salary and all
                                            other payments received or deemed received by him from the Company.

 

		5.	Other
                                            Benefits

 

		5.1	The
                                            Executive shall be entitled to the following benefits during the Appointment:

 

		(a)	the
                                            Company shall bear the Executive’s reasonable entertainment expenses, subject to limits
                                            from time to time set by the Company, in respect of entertainment connected with the Group’s
                                            business for which the Executive shall submit to the Company written evidence of payment
                                            for purposes of reimbursement; and

 

		(b)	the
                                            Company shall bear all reasonable travel, hotel and other out-of-pocket expenses, subject
                                            to limits from time to time set by the Company, incurred by the Executive in or about the
                                            discharge of his duties pursuant to the Appointment for which the Executive shall submit
                                            to the Company written evidence of payment for purposes of reimbursement.

 

In
setting any of the limits referred to in this Clause 5.1, the Company shall have regard to the Executive’s responsibilities and
position in the Company.

 

	5.2	During
                                            the Appointment, if the Remuneration Committee of the Company shall in its sole absolute
                                            discretion deem fit, the Executive may be entitled to participate in such share option scheme
                                            or performance share plan as may be implemented by the Company after obtaining shareholders’
                                            approval, if applicable, upon the terms and conditions of such share option scheme or performance
                                            share plan and subject to the relevant provisions of the Catalist Rules.
	 	 
	5.3	During
                                            the Appointment, the Company shall extend to the Executive and the Executive’s immediate
                                            family such medical, dental benefits and hospital and surgical insurance coverage and personal
                                            accident insurance and long-term and short-term disability insurance in accordance with the
                                            prevailing policies of the Company, as may be approved by the Board from time to time.

 

		6.	Hours
                                            of Work,
                                            Annual Leave and Medical Leave

 

	6.1	The
                                            Executive shall work such hours as may be necessary or appropriate from time to time to carry
                                            out his responsibilities and duties properly and effectively.
	 	 
	6.2	The
                                            Executive shall be entitled in each calendar year up to 21 days of annual leave with full
                                            salary (in addition to statutory holidays) to be taken at such reasonable time or times as
                                            may be approved by the Board. 
	 	 
	6.3	Subject
                                            to the Executive being entitled to be paid during any period of absence from work due to
                                            sickness or injury up to a maximum of 14 days medical leave per calendar year and a maximum
                                            of 60 days hospitalisation leave per calendar year, the Executive shall not be entitled to
                                            be paid in respect of any period during which he has been absent without leave.

 

    	4

    	 

    

 

		7.	Termination

 

	7.1	The
                                            Appointment may be terminated by the Executive hereto giving to the Company not less than
                                            three (3) months’ written notice, or in lieu of notice, payment of an amount equivalent
                                            to the Executive’s Base Salary for three (3) months.
	 	 
	7.2	If
                                            the Company terminates the Appointment of the Executive, the Company shall be obliged to
                                            compensate the Executive a severance payment which will be equivalent to the total remuneration
                                            that would have been paid to the Executive as if he had completed his Term as the Chief Executive
                                            Officer of the Company (“Severance
                                            Payment”). In the event there is a change in control
                                            of the Company, the Executive shall be granted with the option to continue his Appointment
                                            with the Company. If the Executive decides not to continue with the Appointment, the Company
                                            shall be obliged to compensate the Executive an amount equivalent to the Severance Payment.
                                            For the avoidance of doubt, the Severance Payment shall be for the balance of the tenure
                                            of his Term and shall be computed based on the highest annual remuneration, including salaries,
                                            incentive payments and Performance Bonus paid to the Executive in the previous years prior
                                            to the termination of the Appointment. Such Severance Payment shall be paid in cash only.
	 	 
	7.3	Unless
                                            otherwise mutually agreed in writing, the Severance Payment is payable within seven (7) days
                                            from the date termination of the Appointment.
	 	 
	7.4	Notwithstanding
                                            the other provisions of this Agreement and subject to the provisions of the Employment Act,
                                            Cap. 91 of Singapore, the Company shall be entitled to terminate the Appointment forthwith
                                            immediately, but without prejudice to the rights and remedies of the Company for any breach
                                            of this Agreement and to the Executive’s continuing obligations under Clause 7.5, in
                                            any of the following cases:

 

		(a)	if
                                            the Executive is convicted or otherwise found guilty by any court of competent jurisdiction,
                                            or pleads guilty to, any offence involving fraud or dishonesty, or of a felony, serious misdemeanour,
                                            or crime involving moral turpitude; or
	 	 	 
		(b)	if
                                            the Executive commits an act of bankruptcy under applicable law, is declared a bankrupt or
                                            has bankruptcy proceedings commenced against him or any such analogous events occurs under
                                            any provisions under applicable law; or
	 	 	 
		(c)	if
                                            the Executive is convicted of any criminal offence and/or other offences which, in the opinion
                                            of the Board, would affect his position or performance as the Chief Executive Officer of
                                            the Company; or
	 	 	 
		(d)	if
                                            the Executive neglects or refuses, without reasonable cause, to attend to the business of
                                            the Company or any Group Company to which he is assigned duties; or
	 	 	 
		(e)	if
                                            the Executive misappropriates assets of the Company or any Group Company; or
	 	 	 
		(f)	if
                                            the Executive fails to observe and perform any of the duties and obligations imposed by this
                                            Agreement or which are imposed by law; or
	 	 	 
		(g)	if
                                            the Executive otherwise acts in breach of this Agreement; or
	 	 	 
		(h)	if
                                            the Executive becomes of unsound mind or mentally disordered; or
	 	 	 
		(i)	if
                                            the Executive is found to have made any illegal monetary profit or received any gratuities
                                            or other rewards (whether in cash or kind) out of the Company’s or any Group Company’s
                                            affairs; or
	 	 	 
		(j)	if
                                            the Executive is incapacitated by reason of his health or accident from performing his duties
                                            and obligations hereunder and shall have been so incapacitated for a total period of 180
                                            days or more (whether or not consecutive) in the preceding 12 months and no compensation
                                            or liability whatsoever shall be payable or incurred by the Company to the Executive for
                                            termination under Clauses 7.4(a) to (j).

 

    	5

    	 

    

 

		7.5	Upon
                                            termination of the Appointment for whatever reason, the Executive shall:

 

		(a)	deliver
                                            to the Company all correspondences, books, documents, papers, materials, digital storage
                                            media, tapes or other computer material, credit cards, and other property (including confidential
                                            information) relating to the business of the Company or any Group Company which may then
                                            be in his possession or under his power or control and the Executive shall not without written
                                            consent of the Board retain any copies thereof;
	 	 	 
		(b)	if
                                            so requested, send to a duly appointed officer of the Board a signed statement confirming
                                            that he has complied with Clause 7.5(a) above; and
	 	 	 
		(c)	take
                                            all necessary action to resign without claim for compensation from all offices held in the
                                            Company and/or any Group Company and from membership of any organisation acquired by reason
                                            of or in connection with the Appointment and if he shall fail to do so within seven (7) days,
                                            the Company is hereby irrevocably authorised to appoint some person in the Executive’s
                                            name and on the Executive’s behalf to sign any documents and do any act or thing necessary
                                            or requisite to give effect thereto.

 

		7.6	If
                                            before the expiration of this Agreement, the Appointment is terminated by reason of the liquidation
                                            of the Company for the purposes of amalgamation or reconstruction or as part of any arrangement
                                            for the amalgamation of the undertaking of the Company not involving liquidation, the Executive
                                            shall be offered employment with the amalgamated or reconstructed company on the same terms
                                            and conditions which will not be less favourable than the terms and conditions of this Agreement.

 

		8.	Executive’s
                                            Position as an Executive Director of the Company

 

	8.1	The
                                            duties of the Executive as an executive director of the Company shall be subject to the constitution
                                            of the Company and shall be separate from and additional to his duties pursuant to the Appointment.
                                            The Executive’s salary under this Agreement is inclusive of any remuneration to which
                                            the Executive may be entitled as an executive director of the Company.
	 	 
	8.2	Upon
                                            termination of the Appointment for whatever reason the Executive shall, at the request of
                                            the Company, forthwith take all necessary steps (including without limitation, obtaining
                                            any necessary approvals) to resign his position as a director of the Company and/or any Group
                                            Company in writing (and, if so directed by the Board, under seal) without compensation for
                                            loss of office as such director and in the event of his failure to do so within seven (7)
                                            days, the Company is hereby irrevocably authorised to appoint some person in his name and
                                            on his behalf to execute any documents and to do all things requisite to give effect to such
                                            resignation.

 

		9.	Notices

 

		9.1	Any
                                            notice to be given hereunder may be given by letter delivered in person or sent by post or
                                            by email. Such notice shall take effect at the time of delivering such letter, despatching
                                            such email, and on the date immediately following the date of posting if sent by post, if
                                            so delivered, despatched or made to the following addresses or destinations or to such other
                                            addresses or destinations as may from time to time be notified (in accordance with this Clause
                                            9) by the relevant party to the other party:

 

	 	(a)	if
    to the Company: 	Alset
    International Limited
	 	 	 	Address:
                                            7 Temasek Boulevard #29-01B Suntec Tower One Singapore 038987

    

	 	 	 	Email
                                            Address: alan@alsetinternational.com

    

	 	 	 	Attention:
                                            Mr Alan Lui

    

 

	 	(b)	if
    to the Executive: 	Chan
    Heng Fai Ambrose

 

    	6

    	 

    

  

		10.	Miscellaneous

 

	10.1	This
                                            Agreement is governed by, and shall be construed in accordance with, the laws of Singapore.
                                            The parties hereby irrevocably submit to the exclusive jurisdiction of the courts of Singapore.
	 	 
	10.2	This
                                            Agreement contains the entire understanding and agreement between the Company and the Executive
                                            with respect to the Appointment and is in substitution for all previous contracts of service
                                            between the Company and/or any Group Company and the Executive which shall be deemed to have
                                            been terminated by mutual consent as from the date on which this Agreement takes effect.
	 	 
	10.3	The
                                            various provisions of this Agreement are severable and if any provision is held to be invalid,
                                            illegal or unenforceable by any court of competent jurisdiction, then such invalidity, illegality
                                            or unenforceability shall not affect the remaining provisions of this Agreement and the invalid,
                                            illegal or unenforceable provisions shall be interpreted and applied so as to produce the
                                            closest legal, economic and commercial result intended by the parties.
	 	 
	10.4	The
                                            Executive understands that this Agreement is personal to him and that he may not assign his
                                            rights or delegate his duties under this Agreement, in whole or in part, to any other person
                                            or entity (save for any of his personal wholly owned company to be decided by him at his
                                            sole discretion) without the Company’s prior written consent.
	 	 
	10.5	Nothing
                                            in this Agreement is intended to grant to any third party any right to enforce any term and
                                            condition of this Agreement or to confer on any third party any benefits under this Agreement
                                            for the purpose of the Contracts (Rights of Third Parties) Act, Cap. 53B of Singapore and
                                            any re-enactment thereof, the application of which legislation is hereby expressly excluded.

 

[The
remainder of this page is intentionally left blank.]

 

    	7

    	 

    

 

In
witness whereof this Agreement has been entered into by the parties hereto.

 

The
Company

 

	Signed
                                            by Wong Shui Yeung

     

     

     

    For
    and on behalf of

     

    Alset
    International Limited 
	)

     

    )

     

    )
	 
	in
    the presence of:	 	 
	 	 	 
	____________________	 	 
	 	 	 
	Witness’
    signature	 	 
	 	 	 
	Name:	 	 
	 	 	 
	NRIC
    / Passport No.:	 	 

 

The
Executive

 

	Signed
                                            by

     

    Chan
    Heng Fai Ambrose

     

     
	)

     

    )

     

    )
	 
	in
    the presence of:	 	 
	 

    

    
	 	 
	_____________________	 	 
	Witness’
    signature	 	 
	 	 	 
	Name:	 	 
	 	 	 
	NRIC
    / Passport No.:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00343-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00343-of-00352.parquet"}]]